NCT01809769 - Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

July 31, 2015

Conditions

Knee Osteoarthritis

Interventions

BIOLOGICAL

Mesenchymal stem cells low-dose group

Biological: Adipose tissue derived mesenchymal stem cells administrated for intra-articular use

BIOLOGICAL

Mesenchymal stem cells mid-dose group

Biological: Adipose tissue derived mesenchymal stem cells administrated for intra-articular use

BIOLOGICAL

Mesenchymal stem cells high-dose group

Biological: Adipose tissue derived mesenchymal stem cells administrated for intra-articular use

Trial Locations (1)

Department of Rheumatology,Ren Ji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai,China, Shanghai

All Listed Sponsors

collaborator

RenJi Hospital

OTHER

lead

Shanghai AbelZeta Ltd.

INDUSTRY